NCT02183311View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

October 31, 2006

Conditions
Healthy
Interventions
DRUG

BI 1356 BS - single rising dose

DRUG

BI 1356 BS - multiple rising dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY